Owens & Minor (OMI) Competitors $12.52 0.00 (0.00%) (As of 12:33 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends OMI vs. PDCO, MCK, COR, CAH, HSIC, BHVN, HAE, PBH, IMVT, and RNAShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Biohaven (BHVN), Haemonetics (HAE), Prestige Consumer Healthcare (PBH), Immunovant (IMVT), and Avidity Biosciences (RNA). These companies are all part of the "medical" sector. Owens & Minor vs. Patterson Companies McKesson Cencora Cardinal Health Henry Schein Biohaven Haemonetics Prestige Consumer Healthcare Immunovant Avidity Biosciences Owens & Minor (NYSE:OMI) and Patterson Companies (NASDAQ:PDCO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Is OMI or PDCO more profitable? Patterson Companies has a net margin of 2.37% compared to Owens & Minor's net margin of -0.46%. Patterson Companies' return on equity of 19.77% beat Owens & Minor's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-0.46% 14.60% 2.51% Patterson Companies 2.37%19.77%6.66% Do insiders and institutionals hold more shares of OMI or PDCO? 98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.4% of Patterson Companies shares are owned by institutional investors. 3.6% of Owens & Minor shares are owned by company insiders. Comparatively, 1.9% of Patterson Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer OMI or PDCO? In the previous week, Patterson Companies had 8 more articles in the media than Owens & Minor. MarketBeat recorded 11 mentions for Patterson Companies and 3 mentions for Owens & Minor. Owens & Minor's average media sentiment score of 1.37 beat Patterson Companies' score of 0.60 indicating that Owens & Minor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Patterson Companies 4 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, OMI or PDCO? Owens & Minor has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500. Does the MarketBeat Community favor OMI or PDCO? Patterson Companies received 107 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 51.13% of users gave Patterson Companies an outperform vote while only 48.20% of users gave Owens & Minor an outperform vote. CompanyUnderperformOutperformOwens & MinorOutperform Votes25548.20% Underperform Votes27451.80% Patterson CompaniesOutperform Votes36251.13% Underperform Votes34648.87% Do analysts rate OMI or PDCO? Owens & Minor presently has a consensus target price of $18.50, indicating a potential upside of 47.53%. Patterson Companies has a consensus target price of $26.57, indicating a potential downside of 13.99%. Given Owens & Minor's higher probable upside, equities research analysts clearly believe Owens & Minor is more favorable than Patterson Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00Patterson Companies 0 Sell rating(s) 10 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.09 Which has preferable valuation and earnings, OMI or PDCO? Patterson Companies has lower revenue, but higher earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.66B0.09-$41.30M-$0.65-19.29Patterson Companies$6.55B0.42$185.93M$1.7118.06 SummaryPatterson Companies beats Owens & Minor on 12 of the 18 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE ExchangeMarket Cap$966.95M$8.27B$5.16B$19.11BDividend YieldN/A1.99%5.12%3.66%P/E Ratio-19.2922.2387.5140.95Price / Sales0.091.261,136.4517.54Price / Cash2.7111.7043.2321.28Price / Book1.042.294.785.29Net Income-$41.30M$259.21M$120.55M$989.88M7 Day Performance-8.00%-3.62%-1.64%-3.55%1 Month Performance1.54%10.69%14.04%-5.09%1 Year Performance-37.17%-2.57%28.88%11.13% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.4667 of 5 stars$12.52flat$18.50+47.8%-37.2%$965.41M$10.66B-19.2613,700Positive NewsPDCOPatterson Companies4.1571 of 5 stars$31.05-0.1%$26.24-15.5%+9.2%$2.74B$6.57B18.187,600Analyst ForecastMCKMcKesson4.957 of 5 stars$571.06-0.9%$643.43+12.7%+27.6%$72.49B$330.19B29.8451,000CORCencora4.7278 of 5 stars$229.90-1.0%$275.60+19.9%+12.1%$44.44B$638.56M30.9246,000CAHCardinal Health4.816 of 5 stars$117.28-0.7%$126.75+8.1%+16.7%$28.38B$224.45B22.9848,900HSICHenry Schein3.9722 of 5 stars$75.89-0.9%$78.89+4.0%-6.8%$9.46B$12.50B31.4725,000BHVNBiohaven3.6217 of 5 stars$41.67+8.3%$63.00+51.2%-9.5%$4.21B$462.51M-4.11239HAEHaemonetics4.5963 of 5 stars$82.23+1.3%$108.78+32.3%-14.3%$4.13B$1.36B33.693,657Positive NewsPBHPrestige Consumer Healthcare3.821 of 5 stars$82.60+0.4%$85.25+3.2%+27.1%$4.08B$1.11B20.02540Positive NewsIMVTImmunovant1.4579 of 5 stars$27.54+4.8%$47.89+73.9%-37.7%$4.04BN/A-11.84120RNAAvidity Biosciences2.178 of 5 stars$33.82+4.1%$63.60+88.1%+245.3%$4.04B$10.12M-11.28190Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies Patterson Companies Alternatives McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Henry Schein Alternatives Biohaven Alternatives Haemonetics Alternatives Prestige Consumer Healthcare Alternatives Immunovant Alternatives Avidity Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:OMI) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.